Madras HC Clarifies Evidence for Bolar Exemption in Novartis Case
The Madras High Court ruled on the evidentiary requirements for invoking Section 107A for pharmaceutical exports aimed at regulatory approval. The decision aims to provide clearer guidance but raises concerns about burdens on manufacturers.